T. Rowe Price Investment Management, Inc., a registered investment adviser, initiated a new position in Thermo Fisher Scientific Inc. (NYSE:TMO) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 1,328,845 shares of the Healthcare company, valued at approximately $770.0M as of the filing date.
Thermo Fisher Scientific Inc.'s stock currently trades at $515.91 with a market capitalization of $219.4B.
